A  drug discovery and development company with “first-in-class” drugs for respiratory diseases


Investors

Verona Pharma is listed on the London Stock Exchange under the VRP.L ticker. Read more here about investing in Verona Pharma

Verona Pharma shares

Powered by Ekonomys Quotes 6

Pipeline

Verona Pharma has a portfolio of new drugs in development for COPD, asthma, cough and anti-inflammatory indications. See our Pipeline

Pipeline-front

Partners

A key component of Verona Pharma’s business strategy is out-licensing its “first-in-class” drug programmes to suitable development and commercialisation partners. To discuss partnering opportunities, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

Verona Pharma plc, Suite 21 - Alpha House, 100 Borough High Street. London SE1 1LB
Email: This email address is being protected from spambots. You need JavaScript enabled to view it. | Tel: +44 (0)20 7863 3300 | Fax: +44 (0)20 7863 3314
To provide feedback or report problems with the website: This email address is being protected from spambots. You need JavaScript enabled to view it.